Tag: biosimilar coding
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Community Health Presentations: Public Education Resources on Generics
Jul, 29 2026
Drug Take-Back Programs in Your Community: How They Work
Jun, 3 2026
FDA Inspection of Generic Manufacturing Facilities: What to Expect
Mar, 5 2026
Corticosteroid Injections for Joint Pain: What They Do, How Long They Last, and When to Avoid Them
Jan, 5 2026
Top 5 Metformin Alternatives in 2025 for Diabetes Management
Jan, 5 2025